Tech Company Financing Transactions
Nervonik Funding Round
Nervonik, operating out of Los Angeles, secured $13 million in investment from U.S. Venture Partners, Correlation Ventures and Foothill Ventures.
Transaction Overview
Company Name
Announced On
3/4/2025
Transaction Type
Venture Equity
Amount
$13,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to advance its clinical studies, accelerate regulatory clearance, and prepare for commercialization efforts aimed at transforming chronic pain treatment.
Company Information
Company Status
Private & Independent
Industry
Manufacturing
Mailing Address
Undisclosed
Los Angeles, CA Undisclosed
USA
Los Angeles, CA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Nervonik is a California-based med tech company developing the smallest, most advanced, and most power-efficient neuromodulation implants in the world. Our mission is to offer a more advanced and more effective non-narcotic treatment option for chronic neuropathic pain. Our implants rely on next-gen, neural-sensing integrated circuits to deliver an optimized therapy with minimal therapeutic resistance.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Aydin Babakhani
Browse more venture capital transactions:
Prev: 3/4/2025: Odeko venture capital transaction
Next: 3/4/2025: Dominari Securities venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs